Can diffuse optical spectroscopic tomography be used to characterize breast lesions and their response to treatment?

Radiology

Volumn 252, Issue 2, 2009, Pages 330-331

  Hylton, Nola M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

BREAST CANCER; BREAST LESION; CANCER DIAGNOSIS; DIAGNOSTIC IMAGING; DIFFUSE OPTICAL TOMOGRAPHY; ECHOMAMMOGRAPHY; EDITORIAL; HUMAN; MEDICAL TECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL TOMOGRAPHY; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TOMOGRAPHY; TREATMENT RESPONSE; VASCULARIZATION; BREAST TUMOR; COMPUTER ASSISTED DIAGNOSIS; FEMALE; METHODOLOGY; NOTE; PHOTOMETRY; PROGNOSIS; SPECTROSCOPY; TREATMENT OUTCOME;

BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; SPECTRUM ANALYSIS; TOMOGRAPHY, OPTICAL; TREATMENT OUTCOME;

EID: 70249134599     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2522090830     Document Type: Editorial

References (4)

1. Zhu Q, Tannenbaum S, Hegde P, Kane M, Xu C, Kurtzman SH. Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization. Neoplasia 2008;10(10):1028-1040.
2. Cerussi A, Hsiang D, Shah N, et al. Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc Natl Acad Sci U S A 2007;104(10):4014-4019. (Pubitemid 47181570)
3. Choe R, Konecky SD, Corlu A, et al. Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography. J Biomed Opt 2009;14(2):024020.
4. Jiang S, Pogue BW, Carpenter CM, et al. Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes. Radiology 2009;252(2):551-560.